Literature DB >> 10698676

Cotinine and nicotine inhibit each other's calcium responses in bovine chromaffin cells.

P J Vainio1, K Törnquist, R K Tuominen.   

Abstract

Cotinine is the major metabolite of nicotine. It has some biological activity, but its pathophysiological effects are largely unclear. We studied whether cotinine initiates calcium transients or affects those induced by nicotine. In bovine adrenal chromaffin cells labeled with the fluorescent calcium indicator Fura 2, cotinine (0. 32-3.2 mM) concentration-dependently increased the intracellular Ca(2+) concentration ([Ca(2+)](i)). The effect was abolished by omitting extracellular Ca(2+) during the stimulations. Also nicotinic receptor channel blockers hexamethonium (10 microM-1 mM) and chlorisondamine (100 microM), as well as a competitive nicotinic receptor antagonist dihydro-beta-erythroidine (10-100 microM), inhibited the response. Cotinine (0.32-3.2 mM) preincubation for 2 min inhibited both the nicotine-induced and the cotinine-induced increases in [Ca(2+)](i). Also nicotine (3.2-10 microM) inhibited the cotinine-induced increase in [Ca(2+)](i). Tetrodotoxin (1 microM) and thapsigargin (1 microM) pretreatments did not affect the responses to cotinine, while 300 nM nimodipine partially inhibited the cotinine-induced increase in [Ca(2+)](i). The results indicate that cotinine has nicotine-like effects on chromaffin cells. It may also desensitize the nicotinic cholinergic receptors, possibly by acting as a low-affinity agonist at these receptors. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698676     DOI: 10.1006/taap.1999.8863

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

Review 1.  Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.

Authors:  Alvin V Terry; Caterina M Hernandez; Elizabeth J Hohnadel; Kristy P Bouchard; Jerry J Buccafusco
Journal:  CNS Drug Rev       Date:  2005

2.  Cotinine antagonizes the behavioral effects of nicotine exposure in the planarian Girardia tigrina.

Authors:  Daniel J Bach; Matthew Tenaglia; Debra L Baker; Sean Deats; Erica Montgomery; Oné R Pagán
Journal:  Neurosci Lett       Date:  2016-09-08       Impact factor: 3.046

Review 3.  Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder.

Authors:  Cristhian Mendoza; George E Barreto; Alexandre Iarkov; Vadim V Tarasov; Gjumrakch Aliev; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

4.  Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.

Authors:  Kathryn O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2008-02-27       Impact factor: 4.030

Review 5.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

6.  The involvement of mesolimbic dopamine system in cotinine self-administration in rats.

Authors:  Xiaoying Tan; Cynthia M Ingraham; William J McBride; Zheng-Ming Ding
Journal:  Behav Brain Res       Date:  2021-09-23       Impact factor: 3.332

7.  A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.

Authors:  Jane P F Bai; Theodore Sakellaropoulos; Leonidas G Alexopoulos
Journal:  Toxins (Basel)       Date:  2017-03-10       Impact factor: 4.546

Review 8.  Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions.

Authors:  Xiaoying Tan; Kent Vrana; Zheng-Ming Ding
Journal:  Front Behav Neurosci       Date:  2021-10-21       Impact factor: 3.617

9.  Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice.

Authors:  Sagar Patel; J Alex Grizzell; Rosalee Holmes; Ross Zeitlin; Rosalynn Solomon; Thomas L Sutton; Adeeb Rohani; Laura C Charry; Alexandre Iarkov; Takashi Mori; Valentina Echeverria Moran
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

10.  The Influence of Cigarette Smoke Exposure on the Copper Concentration in the Serum Depending on the Use of Menopausal Hormone Therapy.

Authors:  Maria Jasińska-Starczewska; Iwona Szydłowska; Bożena Mroczek; Maria Laszczyńska; Dariusz Chlubek; Ewa Kemicer-Chmielewska; Kornel Chełstowski; Beata Karakiewicz; Sylwester Ciećwież; Andrzej Starczewski
Journal:  Biomed Res Int       Date:  2017-08-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.